Alternative Antibiotics for Cat Bite Not Responding to Augmentin
For a cat bite infection failing Augmentin therapy, switch to intravenous therapy with ampicillin-sulbactam, piperacillin-tazobactam, a carbapenem (ertapenem, imipenem, or meropenem), or a second-generation cephalosporin (cefoxitin), while ensuring adequate wound care and considering surgical debridement if deep tissue involvement is present. 1
Immediate Assessment and Management
When a cat bite fails to respond to amoxicillin-clavulanate, you must first reassess the wound for:
- Deep tissue involvement - Cat bites have a higher proportion of osteomyelitis and septic arthritis compared to dog bites, with 19% developing abscesses 1
- Hand wounds - These carry the greatest risk of infection and serious complications 1, 2
- Pain disproportionate to injury near bone or joint - This suggests periosteal penetration requiring prolonged therapy 1
Why Augmentin May Be Failing
Cat bites present unique challenges:
- 75% contain Pasteurella multocida (versus 50% in dog bites) 1
- 65% harbor anaerobes (versus 50% in dog bites) 1
- Average of 5 different bacterial species per wound, including Staphylococcus, Streptococcus, Bacteroides, Fusobacterium, Porphyromonas, and Capnocytophaga species 1
- Atypical organisms like Mycobacterium chelonae have been reported in cat bites not responding to first-line therapy 3
Recommended Alternative Antibiotic Regimens
Intravenous Options (Preferred for Treatment Failure)
First-line IV alternatives:
- Ampicillin-sulbactam 1.5-3.0 g every 6-8 hours 1
- Piperacillin-tazobactam 3.37 g every 6-8 hours 1
- Carbapenems: Ertapenem 1 g daily, imipenem, or meropenem 1
- Cefoxitin (second-generation cephalosporin) 1 g every 6-8 hours 1
Oral Combination Regimens (If IV Not Feasible)
Doxycycline-based combinations:
- Doxycycline 100 mg twice daily has excellent activity against P. multocida 1
- Must be combined with metronidazole 500 mg three times daily or clindamycin 300 mg three times daily for anaerobic coverage 1
Fluoroquinolone-based combinations:
- Moxifloxacin 400 mg daily provides monotherapy coverage including anaerobes 1
- Levofloxacin 750 mg daily or ciprofloxacin 500-750 mg twice daily plus metronidazole or clindamycin 1
Alternative combination:
- Cefuroxime 500 mg twice daily (good P. multocida activity) plus metronidazole or clindamycin for anaerobic coverage 1
Critical Pitfalls to Avoid
Do NOT use these antibiotics for cat bites:
- First-generation cephalosporins (cephalexin) - poor activity against P. multocida 1
- Penicillinase-resistant penicillins (dicloxacillin) - poor activity against P. multocida 1
- Macrolides (erythromycin) - poor activity against P. multocida 1
- Clindamycin monotherapy - misses P. multocida 1
- Trimethoprim-sulfamethoxazole monotherapy - poor anaerobic coverage 1
Duration and Escalation of Therapy
Standard treatment duration: Continue antibiotics until clinical resolution, typically 7-14 days 1
Extended therapy required for complications:
Essential Adjunctive Measures
Surgical intervention is as important as antibiotics:
- Wound irrigation with sterile normal saline (no iodine or antibiotic solutions needed) 1
- Debridement if deep tissue involvement, but done cautiously to avoid enlarging wound 1
- Do not close infected wounds - allow healing by secondary intention 1
- Elevation of affected extremity, especially if swollen 1
When to Hospitalize
Admit for IV antibiotics if:
- Failure of oral therapy (your current scenario)
- Signs of deep tissue infection (osteomyelitis, septic arthritis, tenosynovitis)
- Systemic toxicity or bacteremia
- Hand wounds with significant involvement
- Immunocompromised patients (asplenia, hepatic disease) at risk for Capnocytophaga canimorsus sepsis 1
Special Considerations
Consider atypical organisms if standard broad-spectrum therapy fails - rare cases of Mycobacterium chelonae have been reported in cat bites, particularly related to the cat's diet and food microbiome 3
MRSA coverage may be needed if risk factors present, though standard animal bite regimens do not routinely cover MRSA 1